In the latest trading session, Recursion Pharmaceuticals (RXRX) closed at $5.52, marking a +2.41% move from the previous day. The stock outperformed the S&P 500, which registered a daily gain of 0.54% ...

Back in high school chemistry, I remember waiting with my bench partner for crystals to form on our stick in the cup of blue ...

Recursion Pharmaceuticals RXRX shares have gained 5.5% in a month. The stock gained momentum after the company announced the ...

Recursion is a powerful technique used to solve problems with repeating patterns, and is a fundamental structure in software. To date there is no known general way to apply a recursive solution to ...

Recursion's share price has dropped in recent weeks due to poor clinical trial data, but its most mature assets are not reflective of its current capabilities. Read more here.

Recursion strengthened its tech stack through partnerships and collaborations with big players. Read why I will remain on the sidelines of RXRX stock.